How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Credit: VentureBeat made with OpenAI ChatGPT-Images-2.0 Meta today released Muse Code, a terminal-based AI coding agent now in beta, alongside Muse Spark 1.2, a coding-focused update to its Muse Spark ...

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Bonus bet amounts not returned with winnings. Min. deposit required. Must register with app only. T&Cs, time limits, and exclusions apply. 21+. GAMBLING PROBLEM? CALL ...

Anthropic will watermark text generated by its models, including Claude, to comply with European regulations, the company now says. The AI model maker confirmed the watermarking in an updated support ...

Jeff Dean, who for years was one of Google’s most important executives, is leading the new artificial intelligence company with the backing of Google. By Cade Metz Reporting from Palo Alto, Calif.

Earlier today, OpenAI launched GPT-5.6-Cyber, a specialized model designed to perform advanced vulnerability research and exploit development for approved defenders — including categories of work that ...